Search

Your search keyword '"Sattar N"' showing total 1,723 results

Search Constraints

Start Over You searched for: Author "Sattar N" Remove constraint Author: "Sattar N" Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,723 results on '"Sattar N"'

Search Results

1. GDF15 linked to maternal risk of nausea and vomiting during pregnancy

2. NMR metabolomics-guided DNA methylation mortality predictors

3. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

4. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

5. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

7. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group

8. The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals:An application to the PROSPER randomised controlled trial

9. GDF15 linked to maternal risk of nausea and vomiting during pregnancy

11. Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval

14. Effect of empagliflozin on CMR-estimated pulmonary capillary wedge pressure in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

16. Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

17. Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

18. Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy

19. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

20. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

22. Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England

23. Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England

24. The Remote Diet Intervention to REduce long Covid symptoms Trial (ReDIRECT) – dietary profile of the study participants at baseline

25. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

28. Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF

30. Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF

31. Socioeconomic deprivation: an important largely unrecognized risk factor in primary prevention of cardiovascular disease

32. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

33. Empagliflozin in heart failure with a preserved ejection fraction

35. Author Correction: Genetic analysis of over half a million people characterises C-reactive protein loci (Nature Communications, (2022), 13, 1, (2198), 10.1038/s41467-022-29650-5)

38. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

39. Cardiovascular and renal outcomes with empagliflozin in heart failure

40. Beyond ten-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease

41. Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest

42. Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit

43. Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress

44. No Effect of Levothyroxine on Hemoglobin in Older Adults With Subclinical Hypothyroidism: Pooled Results From 2 Randomized Controlled Trials

45. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

46. Stroke genetics informs drug discovery and risk prediction across ancestries

47. The Association between Serum Lipids and Intraocular Pressure in 2 Large United Kingdom Cohorts.

48. A saturated map of common genetic variants associated with human height

49. Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit

50. Genetic analysis of over half a million people characterises C-reactive protein loci

Catalog

Books, media, physical & digital resources